Melanie M. Makhija, MD

Clinical and Community Trials

Research Interests

  • Food Allergy
  • Eosinophilic Esophagitis
  • Primary Immune Deficiency

Biography

  • Attending Physician, Allergy & Immunology, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Associate Professor of Pediatrics (Allergy and Immunology), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in Allergy and Immunology, Hospital for Sick Children 2008-2010
  • Residency in Pediatrics, Hospital for Sick Children 2005-2008
  • University of Toronto Faculty of Medicine 2005

Clinical Studies

Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)

Recruiting

Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

Recruiting

Preventing Asthma in High Risk Kids

Recruiting

Peanut Oral Immunotherapy Study of Early Intervention for Desensitization

Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)

Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

Recruiting

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

Recruiting

Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy

Publications

Feb. 26, 2024

Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.

May. 10, 2023

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.

Feb. 14, 2023

Accelerating Food Allergy Research: Need for a Data Commons.

See all publications

Similar Researchers

Basic and Preclinical Science

Patrick C. Seed, MD, PhD, FIDSA

Seed Laboratory

Research Interests

Microbiome, Host-microbial interactions, Infectious diseases, Molecular pathogenesis

Recent Publication

Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment.

Jan. 11, 2024
Basic and Preclinical Science

Bria M. Coates, MD

Principal Investigator

Coates Laboratory

Research Interests

Influenza, Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome Coronavirus 2, Innate Immunity, Children, Lung Injury

Recent Publication

Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023.

Sep. 29, 2023
Clinical and Community Trials

Sherif Badawy, MD

Research Interests

Sickle Cell Disease, Thalassemia, Non-malignant Hematology, Medication Adherence, Quality of Life, Patient-reported Outcomes, Mobile Health or Health, Digital Behavioral Interventions

Recent Publication

Real-world evidence: Long-term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years.

Mar. 01, 2024
Basic and Preclinical Science

Joshua B. Wechsler, MD, MS

Wechsler Laboratory

Research Interests

Eosinophilic esophagitis, Ulcerative colitis, Gastrointestinal allergies and inflammation, Immunology, GI mast cell activation, Histamine, Eosinophilic gastritis, Eosinophilic gastroenteritis, Eosinophilic colitis, Hypermobile connective tissue disease, Deconditioning and dysautonomia

Recent Publication

Role of Mast Cells in Eosinophilic Gastrointestinal Diseases.

Feb. 19, 2024
Clinical and Community Trials

Jenna E. Rossoff, MD

Research Interests

Pediatric Oncology, Leukemia, Infectious Complications of Cancer Therapy

Recent Publication

Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.

Dec. 07, 2023
Basic and Preclinical Science

Anne H. Rowley, MD

Principal Investigator

Rowley Laboratory

Research Interests

Kawasaki Disease, Antibody Responses to Infectious Diseases

Recent Publication

Analysis of Plasmablasts from Children with Kawasaki Disease Reveals Evidence of a Convergent Antibody Response to a Specific Protein Epitope.

Feb. 22, 2023